These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 33837124)

  • 21. Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer.
    Stump CT; Roehle K; Manjarrez Orduno N; Dougan SK
    Open Biol; 2021 Nov; 11(11):210245. PubMed ID: 34784792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy.
    Liu Z; Yu Z; Chen D; Verma V; Yuan C; Wang M; Wang F; Fan Q; Wang X; Li Y; Ma Y; Wu M; Yu J
    Cancer Commun (Lond); 2022 Oct; 42(10):971-986. PubMed ID: 35962977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8
    Zou Z; Shen J; Xue D; Li H; Xu L; Cao W; Wang W; Fu YX; Peng H
    Nat Commun; 2024 Jun; 15(1):4701. PubMed ID: 38830882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
    Zhang X; Niedermann G
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.
    Crosby EJ; Acharya CR; Haddad AF; Rabiola CA; Lei G; Wei JP; Yang XY; Wang T; Liu CX; Wagner KU; Muller WJ; Chodosh LA; Broadwater G; Hyslop T; Shepherd JH; Hollern DP; He X; Perou CM; Chai S; Ashby BK; Vincent BG; Snyder JC; Force J; Morse MA; Lyerly HK; Hartman ZC
    Clin Cancer Res; 2020 Sep; 26(17):4670-4681. PubMed ID: 32732224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorin e6-associated photodynamic therapy enhances abscopal antitumor effects via inhibition of PD-1/PD-L1 immune checkpoint.
    Gurung P; Lim J; Shrestha R; Kim YW
    Sci Rep; 2023 Mar; 13(1):4647. PubMed ID: 36944686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated photodynamic therapy mediates the abscopal effect through multiple innate and adaptive immune responses with and without immune checkpoint therapy.
    Lou J; Aragaki M; Bernards N; Chee T; Gregor A; Hiraishi Y; Ishiwata T; Leung C; Ding L; Kitazawa S; Koga T; Sata Y; Ogawa H; Chen J; Kato T; Yasufuku K; Zheng G
    Biomaterials; 2023 Jan; 292():121918. PubMed ID: 36442438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a
    Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z
    Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476
    [No Abstract]   [Full Text] [Related]  

  • 29. PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8
    Yoon YN; Lee E; Kwon YJ; Gim JA; Kim TJ; Kim JS
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PI3Kαδ Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model.
    Chang WI; Han MG; Kang MH; Park JM; Kim EE; Bae J; Ahn S; Kim IA
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):845-858. PubMed ID: 33642128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination low-dose cyclophosphamide with check-point blockade and ionizing radiation promote an abscopal effect in mouse models of melanoma.
    Luo X; Zeng M
    J Cancer Res Ther; 2024 Apr; 20(2):718-725. PubMed ID: 38687945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoengineering-based anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy through T cell engagement.
    Pan Y; Xue Q; Yang Y; Shi T; Wang H; Song X; Luo Y; Liu W; Ren S; Cai Y; Nie Y; Song Z; Liu B; Li JP; Wei J
    Cell Rep Med; 2024 Jun; 5(6):101590. PubMed ID: 38843844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV
    Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ
    J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Cheng Y; Lemke-Miltner CD; Wongpattaraworakul W; Wang Z; Chan CHF; Salem AK; Weiner GJ; Simons AL
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy.
    Buchwald ZS; Nasti TH; Lee J; Eberhardt CS; Wieland A; Im SJ; Lawson D; Curran W; Ahmed R; Khan MK
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.
    Rodríguez-Ruiz ME; Rodríguez I; Mayorga L; Labiano T; Barbes B; Etxeberria I; Ponz-Sarvise M; Azpilikueta A; Bolaños E; Sanmamed MF; Berraondo P; Calvo FA; Barcelos-Hoff MH; Perez-Gracia JL; Melero I
    Mol Cancer Ther; 2019 Mar; 18(3):621-631. PubMed ID: 30683810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
    Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB
    Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.
    Ji D; Song C; Li Y; Xia J; Wu Y; Jia J; Cui X; Yu S; Gu J
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature.
    Watanabe T; Firat E; Scholber J; Gaedicke S; Heinrich C; Luo R; Ehrat N; Multhoff G; Schmitt-Graeff A; Grosu AL; Abdollahi A; Hassel JC; von Bubnoff D; Meiss F; Niedermann G
    Cancer Immunol Immunother; 2020 Sep; 69(9):1823-1832. PubMed ID: 32350591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
    Wang D; Jiang W; Zhu F; Mao X; Agrawal S
    Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.